| ¿µ¹® | androgen | ÇÑ±Û | ³²¼ºÈ£¸£¸ó, ¾Èµå·Î°Õ |
|---|---|---|---|
| ¼³¸í | ³²¼ºÀÇ ÀÌÂ÷ ¼ºÂ¡À» ³ªÅ¸³»°Ô Çϴ ȣ¸£¸ó. Å×½ºÅ佺Å×·Ð(testosterone), ¾Èµå·Î½ºÅ×·Ð(androsterone) µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | resistance | ÇÑ±Û | ³»¼º, ÀúÇ×¼º |
|---|---|---|---|
| ¼³¸í | ¨ç ¾à¹°ÀÇ ¹Ýº¹ º¹¿ë¿¡ ÀÇÇØ ¾àÈ¿°¡ ÀúÇÏÇÏ´Â Çö»ó. ¨è ¼¼±Õ µûÀ§ÀÇ º´¿øÃ¼°¡ ÈÇÐ ¿ä¹ýÁ¦³ª Ç×»ý ¹°ÁúÀÇ °è¼Ó »ç¿ë¿¡ ´ëÇÏ¿© ³ªÅ¸³»´Â ÀúÇ×¼º. ¼¼±ÕÀÇ ³»¼ºÈ¹µæÀÇ ¸ÞÄ¿´ÏÁò¿¡ ´ëÇØ¼´Â ¼¼Æ÷ÀÇ ±¸Á¶(¸®Æ÷Á», ¼¼Æ÷¸·) º¯È, ´ë»ç°èÀÇ º¯È, µ¹¿¬º¯ÀÌ µî¿¡ ÀÇÇÑ ¾à¹°°¨¼ö¼º ÀúÇÏ µîÀÌ ÃßÃøµÇ°í ÀÖ´Ù. ÇÑÆí ´Ù¸¥ ¾à¹°¿¡µµ ³»¼ºÀ» ³ªÅ¸³»´Â ±³Â÷³»¼º°ú, ¿©·¯ Á¾·ùÀÇ ¾à¹°¿¡ µ¿½Ã¿¡ ³»¼ºÀ» ȹµæÇÑ »óŸ¦ ´ÙÁ¦ ³»¼ºÀ̶ó°í ÇÑ´Ù. 3. ȯ°æ Á¶°ÇÀÇ º¯È¿¡ °ßµô ¼ö ÀÖ´Â »ý¹°ÀÇ ¼ºÁú. ³»¿¼º, ³»ÇѼº µûÀ§°¡ ÀÖ´Ù. |
||
| ¿µ¹® | drug resistance | ÇÑ±Û | ¾à¹°³»¼º |
|---|---|---|---|
| ¼³¸í | 1. ÈÇпä¹ýÁ¦³ª Ç×»ý¹°ÁúÀÇ ¾î¶² ÀÏÁ¤ ³óµµ·Î ¼¼±ÕÀ» Á×À̰ųª Áõ½ÄÀúÇØ¸¦ ¹Þ´Â °ÍÀ» ÀÌ ÈÇпä¹ýÁ¦³ª Ç×»ý¹°Áú¿¡ °¨¼ö¼ºÀÌ ÀÖ´Ù°í Çϴµ¥, ÀÌ °¨¼ö¼ºÀÌ ¾ø°Ô µÈ »ýŸ¦ ÀúÇ×¼ºÀ̶óµç°¡ ³»¼ºÀ̶ó°í ¸»ÇÑ´Ù. µû¶ó¼ º¯À̹̻ý¹°ÀÇ ¾àÁ¦¿¡ ´ëÇÑ ÀÚÇ×¼ºÀ̶óµç°¡ ³»¼ºÀ̶ó°í ¸»ÇÑ´Ù. 2. ÀǾàǰÀ» °è¼Ó º¹¿ëÇϸé Á¡Â÷ Áõ·®ÇÏÁö ¾ÊÀ¸¸é È¿·ÂÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ¼ºÁú. ÀÌ·¯ÇÑ ¶§¸¦ ¾àÁ¦³»¼ºÀÌ »ý°å´Ù°í ÇÑ´Ù. ¸ðµç ¹Ì»ý¹°Àº °¨¼ö¼ºÀ» °¡Áö´Â ¾à¹°¿¡ ÀÇÇÏ¿© »ç¸êµÇÁö¸¸, ¼Ò¼öÀÇ °ÍÀº »ì¾Æ³²¾Æ ±×°ÍÀÌ ÁøÈµÊÀ¸·Î½á »ç¸êÇÏÁö ¾Ê´Â ¼ö°¡ ÀÖ´Ù. ¶Ç, ÃÖÃÊ¿¡´Â °¨¼ö¼ºÀ» °¡Áö°í ÀÖ´ø ±ÕÀÌ Â÷Â÷ ³»¼º±ÕÀ¸·Î µÇ±âµµ ÇÑ´Ù. ¸¹Àº º´¿ø±ÕÀº °¨¼ö¼ºÀÌ ÀÖ´Â ÀǾàǰ¿¡ ´ëÇÏ¿© ³»¼ºÀÌ »ý±ä´Ù. °¡Àå °íµµÀÇ ³»¼º±ÕÀÌ »ý±â±â ½¬¿î °ÍÀº ½ºÆ®·¾Å丶À̽ÅÀε¥ °áÇÙ±Õ°ú ±×¶÷À½¼º±Õ¿¡ ´ëÇÏ¿© ½±°Ô ³»¼ºÀÌ »ý±ä´Ù. Æä´Ï½Ç¸°À̳ª Åׯ®¶ó½ÃŬ¸°(¾ÆÅ©·Î¸¶À̽Å) µîÀÇ Ç×»ý¹°Áúµµ ³»¼ºÀÌ »ý±â±â ½¬¿ì¹Ç·Î, »ç¿ëÇÒ ¶§´Â ÀûÀÀÀ» Àß È®ÀÎÇÏ¿© Çʿ䷮À» Á¤ÇÏ°í ¿¬¿ëÀ» ÇÇÇÑ´Ù. °°Àº È¿°ú°¡ ÀÖ´Â ´Ù¸¥ Á¾·ùÀÇ ¾àÁ¦¸¦ ¼Ò·®¾¿ 2, 3Á¾ º´¿ëÇÏ¸é ³»¼ºÀÇ ¹ß»ýÀÌ Å©°Ô ¾ïÁ¦µÈ´Ù´Â °ÍÀÌ ¾Ë·ÁÁ® ÀÖ´Ù. °áÇÙ¾àÀ¸·Î¼ ½ºÆ®·¾Å丶À̽Űú ÆÄ½º, ¶Ç´Â À̼ҴϾÆÁöµå¸¦ º´¿ëÇÏ´Â °Í µîÀÌ ±× ¿¹ÀÌ´Ù. |
||
| ¿µ¹® | resistance | ÇÑ±Û | ÀúÇ× |
|---|---|---|---|
| ¼³¸í | ¨ç¾à¹°ÀÇ ¹Ýº¹ º¹¿ë¿¡ ÀÇÇØ ¾àÈ¿°¡ ÀúÇÏÇÏ´Â Çö»ó. ¨è ¼¼±Õ µûÀ§ÀÇ º´¿øÃ¼°¡ ÈÇÐ ¿ä¹ýÁ¦³ª Ç×»ý ¹°ÁúÀÇ °è¼Ó »ç¿ë¿¡ ´ëÇÏ¿© ³ªÅ¸³»´Â ÀúÇ×¼º. ¼¼±ÕÀÇ ³»¼ºÈ¹µæÀÇ ¸ÞÄ¿´ÏÁò¿¡ ´ëÇØ¼´Â ¼¼Æ÷ÀÇ ±¸Á¶(¸®Æ÷Á», ¼¼Æ÷¸·) º¯È, ´ë»ç°èÀÇ º¯È, µ¹¿¬º¯ÀÌ µî¿¡ ÀÇÇÑ ¾à¹°°¨¼ö¼º ÀúÇÏ µîÀÌ ÃßÃøµÇ°í ÀÖ´Ù. ÇÑÆí ´Ù¸¥ ¾à¹°¿¡µµ ³»¼ºÀ» ³ªÅ¸³»´Â ±³Â÷³»¼º°ú, ¿©·¯ Á¾·ùÀÇ ¾à¹°¿¡ µ¿½Ã¿¡ ³»¼ºÀ» ȹµæÇÑ »óŸ¦ ´ÙÁ¦ ³»¼ºÀ̶ó°í ÇÑ´Ù. ¨é ȯ°æ Á¶°ÇÀÇ º¯È¿¡ °ßµô ¼ö ÀÖ´Â »ý¹°ÀÇ ¼ºÁú. ³»¿¼º, ³»ÇѼº µûÀ§°¡ ÀÖ´Ù. |
||
| IR | drop of voltage across a resistor produced by a current; ileal resection; immune response; immunizat... |
|---|---|
| AR | absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista... |
| POSSUM | Pictures of Standard Syndromes and Undiagnosed Malformations |
| ER | efficiency ratio; epigastric region; ejection rate; electroresection; emergency room; endoplasmic re... |
| SR | sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat... |
| ACS | Acute Coronary Syndromes |
|---|---|
| CMS | Congenital Myasthenic Syndromes |
| EDS | EHLERS-DANLOS SYNDROMES |
| OFDS | Oral-Facial-Digital syndromes |
| APC resistance | Resistance to activated protein C |
| androgen resistance syndromes | A class of disorders associated with 5a-steroid reductase deficiency, testicular feminization, and related disorders. Compare: steroid 5a-reductase, Reifenstein's syndrome, infertile male syndrome, testicular feminization syndrome. (05 Mar 2000) |
|---|
| adrenal androgen | Any androgenic hormone of adrenocortical origin; e.g., dehydroepiandrosterone (and its sulfate), androstenedione, 11b-hydroxyandrostenedione. (05 Mar 2000) |
|---|---|
| adrenal androgen-stimulating hormone | A putative pituitary hormone that may be responsible for increased secretion of adrenal androgens at the time of puberty. (05 Mar 2000) |
| androgen | <endocrinology> General term for any male sex hormone in vertebrates. Androgens may be used in patients with breast cancer to treat recurrence of the disease. (14 May 1997) |
| androgen antagonists | Compounds which inhibit or antagonise the biosynthesis or actions of androgens. (12 Dec 1998) |
| androgen binding protein | A protein secreted by testicular Sertoli cells along with inhibin and mullerian inhibiting substance. Androgen binding protein probably maintains a high concentration of androgen in the seminiferous tubules. (05 Mar 2000) |
| androgen-binding proteins | Carrier proteins produced in the sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. Participate in the transport of androgens; include also synthetic androgens binding proteins. (12 Dec 1998) |
| androgen-dependent secretory protease | <enzyme> Glycoprotein from dog prostate; hydrolyzes arginine and lysine-containing amide and ester protease substrates Registry number: EC 3.4.99.- Synonym: ads-protease (26 Jun 1999) |
| androgen unit | The androgenic activity of 100 ug (0.1 mg) of crystalline androsterone as assayed by the comb growth response in capons. (05 Mar 2000) |
| receptors, androgen | Proteins, generally found in the cytoplasm, that specifically bind androgens and mediate their cellular actions. The complex of the androgen and receptor migrates to the nucleus where it induces transcription of specific segments of DNA. (12 Dec 1998) |
| aortic arch syndromes | Any of a group of disorders leading to occlusion of the arteries arising from the aortic arch. Such occlusion may be caused by atherosclerosis, arterial embolism, syphilitic or tuberculous arteritis, etc. (12 Dec 1998) |
| malabsorption syndromes | General term for syndromes of malnutrition due to failure of normal intestinal absorption of nutrients. (12 Dec 1998) |
| paraneoplastic syndromes | In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumour cell metabolites or other products. (12 Dec 1998) |
| pathologic startle syndromes | A group of disorders characterised by markedly exaggerated startle reflex and other exaggerated stimulus-induced responses. Includes hyperexplexia and probably latah and the jumping Frenchman of Maine syndrome. (05 Mar 2000) |
| chromosomal instability syndromes | A group of mendelian conditions associated with chromosomal instability and breakage in vitro, they often manifest an increased tendency to certain types of malignancies. See: Bloom's syndrome, fragile X syndrome, xeroderma pigmentosum. (05 Mar 2000) |
| compartment syndromes | Conditions in which increased pressure within a limited space compromises the circulation and function of tissue within that space. Compartmentation involves mainly the leg but also involved are the forearm, arm, thigh, shoulder, and buttock. Some of the causes of increased pressure are trauma, tight dressings, haemorrhage, and exercise. Sequelae include nerve compression, paralysis, and contracture. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|